AngioDynamics to Present at UBS 2006 Global Life Sciences Investor ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 20, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) announced that Joseph G. Gerardi, AngioDynamics' chief financial officer, will present at the UBS 2006 Global Life Sciences Conference on Wednesday, September 27, 2006, at 2:00 PM Eastern Time. The conference will be held at the Grand Hyatt Hotel in New York City from September 25 through September 28, 2006.

Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of AngioDynamics' web site www.angiodynamics.com a few minutes prior to start time to download any necessary software.

The UBS Global Life Sciences Conference will feature representatives from over 350 companies from the following major life sciences sectors: biotechnology, life sciences (genomics and tools), medical technology, pharmaceuticals and specialty pharmaceuticals.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products, and venous products. More information is available at www.angiodynamics.com.

CONTACT: AngioDynamics, Inc.
Joe Gerardi, 800-772-6446 x115
www.AngioDynamics.com
or
Lippert/Heilshorn & Associates, Inc. (Investor Relations)


Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com



SOURCE: AngioDynamics, Inc.